Taku Kikuchi

23PUBLICATIONS
39CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cardiology (incl. cardiovascular diseases)Gene and molecular therapyMedical virologyMedical mycology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (23)

|Jun 02, 2026
Real-world outcomes of idecabtagene vicleucel in relapsed/refractory multiple myeloma: A single-centre experience.

|Jan 06, 2026
Prognostic significance of cardiac biomarkers in patients with AL amyloidosis treated with a daratumumab-based regimen.

Taku Kikuchi, Ukyo Kondo, Shotaro Sugita

|Dec 15, 2025
Publisher Correction: Smoldering multiple myeloma: advances in diagnosis and risk stratification, and evolving therapeutic strategies.

Taku Kikuchi

|Dec 03, 2025
Outcomes of elranatamab in relapsed/refractory multiple myeloma: prognostic impact of monocyte count, MyCARe, and R2-ISS.

Taku Kikuchi, Shotaro Sugita, Ukyo Kondo

|Dec 01, 2025
Baseline Cytomegalovirus Immunoglobulin G Levels Predict Reactivation in Patients With Multiple Myeloma Receiving Elranatamab.

Ukyo Kondo, Taku Kikuchi, Shotaro Sugita

|Nov 01, 2025
Smoldering multiple myeloma: advances in diagnosis and risk stratification, and evolving therapeutic strategies.

Taku Kikuchi

Pageof 4

Frequent Collaborators

2 joint publications

Takehiko Mori

2 joint publications

Keisuke Kataoka

1 joint publications

Rie Yamazaki

1 joint publications

Mamoru Shibata